Esperion Therapeutics
ESPR
ESPR
172 hedge funds and large institutions have $1.62B invested in Esperion Therapeutics in 2019 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 55 increasing their positions, 41 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
34% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 41
13% more funds holding
Funds holding: 152 → 172 (+20)
2.42% more ownership
Funds ownership: 99.48% → 101.9% (+2.4%)
Holders
172
Holding in Top 10
6
Calls
$40.9M
Puts
$30.3M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$16.6M | |
| 3 | +$16.1M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$12.8M |
| 5 |
Millennium Management
New York
|
+$10.5M |
Top Sellers
| 1 | -$24.7M | |
| 2 | -$20.3M | |
| 3 | -$17.7M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$13.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.17M |